Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.740
+0.120 (3.31%)
At close: Aug 13, 2025, 4:00 PM
3.750
+0.010 (0.27%)
After-hours: Aug 13, 2025, 6:58 PM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,487,220
Market Cap
303.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 2 hours ago - Altimmune, Inc. (ALT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 hours ago - These Analysts Slash Their Forecasts On Altimmune Following Q2 Results - Benzinga
- 1 day ago - Altimmune Announces Second Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 2 days ago - Altimmune Board of Directors Appoints Jerry Durso as Chairman - GlobeNewsWire
- 8 days ago - Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 - GlobeNewsWire
- 25 days ago - ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 5 weeks ago - Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD) - GlobeNewsWire
- 6 weeks ago - Altimmune's Fatty Liver Candidate Faces Differentiation Doubts - Benzinga